The global cancer treatment demand is likely to grow at around 7% to 7.8% CAGR during the forecast period from 2022 and 2032. Growth in the market is primarily driven by increasing prevalence of laryngeal cancer and growing popularity of effective treatments like radiotherapy and chemotherapy.
| Report Attribute | Details |
| Glottic Cancer Treatment Market Projected Growth Rate (2022-2032) | 7% - 7.8% CAGR |
Glottic cancer is a type of cancer that forms in tissues of the larynx or vocal cords. Presence of this cancer causes various symptoms ranging from mild ones like a persistent cough, hoarseness, sore throat and abnormal lump formation to severe ones like swallowing and breathing difficulties. If glottic cancer remains untreated it can spread to other sections of the neck and lungs and can thus be extremely fatal. As a result, demand for glottic cancer treatment is witnessing a huge upsurge and the trend is likely to continue in the future.
Various treatment options such as non-surgical therapy, radiation, chemotherapy, and combinational therapy are available for minimizing the symptoms and treating glottic cancer depending on the stage of the cancer.
For early stages of glottic cancer, treatment options like radiation and endoscopic excision are highly suitable, while for moderate to advanced stages of glottic cancer, treatment with combinational therapy is highly recommended. Similarly for people with last stages or people who do not respond to radiation therapy and chemotherapy, surgery-based treatment is the last option.
The robust expansion of glottic cancer treatment market is attributable to rising prevalence of glottic cancer worldwide, growing health awareness among people, advancements in cancer research, and increasing government initiatives.
Rise in the number of larynx cancer cases due to excessive smoking and drinking is perhaps one of the major factors accelerating the growth of glottic cancer treatment market. As per the Global Cancer Observatory (GCO), there were around 184615 new cases of larynx cancer reported in 2020 worldwide. About 60% of the laryngeal cancers start in the area containing the vocal cords (glottis).
Similarly, growing awareness among people regarding glottic cancer, its symptoms and treatment will continue to act as a catalyst for the growth of glottic cancer treatment market during the assessment period.
In addition to this, rising geriatric population along with growing popularity of radiation therapy and chemotherapy for their effectiveness will further boost the growth of glottic cancer treatment market in future. It has been observed that most of people diagnosed with laryngeal cancer are 55 or older (American Cancer Society).
Despite its optimistic stance, glottic cancer treatment market is facing various challenges that are restraining its growth. Some of these factors are the high cost of glottic cancer treatments, side effects associated with treatments like radiation and chemotherapy, and lack of awareness about the availability of various glottic cancer treatments across some emerging nations.
North America was the leading market for glottic cancer treatment in 2022 and is projected to retain its dominance during the assessment period, owing to the rising prevalence of laryngeal cancer, high level of awareness among people regarding cancer and its treatment, increase in smoking rates, and heavy presence of leading market players.
The United States remains the leading market for glottic cancer treatment across North America due to high patient pool, rise in smoking and drinking habits, and advancements in cancer research.
According to the American Cancer Society, there will be around 12470 new cases of laryngeal cancer across the United States in 2022 while about 3820 people will die from it. This will generate lucrative growth avenues within the glottis cancer treatment market across the country.
Similarly, rising geriatric population along with increasing governmental support and introduction of reimbursement policies will further expand the size of glottic cancer treatment market across North America during the forecast period.
According to Future Market Insights, Europe will continue to remain the second most lucrative market for glottic cancer treatments, growing at a healthy CAGR over the forecast period. Growth in the market is driven by rising incidence of glottic cancer, increase in smoking rates, growing health awareness among people, and large presence of end user verticals.
Demand for glottic cancer treatments is particularly high across countries like the U.K., Netherlands, and Germany due to availability of better cancer specialists, presence of well-established medical industry, and growing medical tourism.
Some of the key participants present in the global glottic cancer treatment market include Novartis, Eli Lilly and Company, Merck & Co., Inc, Cipla Ltd., F. Hoffmann-la Roche AG, Amgen Inc., Biocon, Bristol-Myers Squibb, Engeneic Ltd, Pfizer Inc., Celgene Corporation, and Teva Pharmaceutical Industries Ltd. among others.
The presence of these large numbers of participants makes the global glottic cancer treatment market highly competitive in nature. Leading players are adopting various growth strategies such as partnerships, mergers, acquisitions, and collaborations to gain a competitive edge in the market and expand their global footprint. Besides this, they are investing heavily in research and development activities to advance in cancer treatments.
| Report Attribute | Details |
| Growth Rate | CAGR of 7% - 7.8% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2020 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
By Treatment Type:
By End User:
By Region:
At what rate will the global glottic cancer treatment market grow?
Which is the most dominant market for glottic cancer treatment?
Novartis, Eli Lilly and Company, Merck & Co., Inc, Cipla Ltd., and Amgen Inc. are some prominent glottic cancer treatment providers.
Our Research Products
The "Full Research Suite" delivers actionable market intel, deep dives on markets or technologies, so clients act faster, cut risk, and unlock growth.
The Leaderboard benchmarks and ranks top vendors, classifying them as Established Leaders, Leading Challengers, or Disruptors & Challengers.
Locates where complements amplify value and substitutes erode it, forecasting net impact by horizon
We deliver granular, decision-grade intel: market sizing, 5-year forecasts, pricing, adoption, usage, revenue, and operational KPIs—plus competitor tracking, regulation, and value chains—across 60 countries broadly.
Spot the shifts before they hit your P&L. We track inflection points, adoption curves, pricing moves, and ecosystem plays to show where demand is heading, why it is changing, and what to do next across high-growth markets and disruptive tech
Real-time reads of user behavior. We track shifting priorities, perceptions of today’s and next-gen services, and provider experience, then pace how fast tech moves from trial to adoption, blending buyer, consumer, and channel inputs with social signals (#WhySwitch, #UX).
Partner with our analyst team to build a custom report designed around your business priorities. From analysing market trends to assessing competitors or crafting bespoke datasets, we tailor insights to your needs.
Supplier Intelligence
Discovery & Profiling
Capacity & Footprint
Performance & Risk
Compliance & Governance
Commercial Readiness
Who Supplies Whom
Scorecards & Shortlists
Playbooks & Docs
Category Intelligence
Definition & Scope
Demand & Use Cases
Cost Drivers
Market Structure
Supply Chain Map
Trade & Policy
Operating Norms
Deliverables
Buyer Intelligence
Account Basics
Spend & Scope
Procurement Model
Vendor Requirements
Terms & Policies
Entry Strategy
Pain Points & Triggers
Outputs
Pricing Analysis
Benchmarks
Trends
Should-Cost
Indexation
Landed Cost
Commercial Terms
Deliverables
Brand Analysis
Positioning & Value Prop
Share & Presence
Customer Evidence
Go-to-Market
Digital & Reputation
Compliance & Trust
KPIs & Gaps
Outputs
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Blood Cancer Treatment Market Growth – Trends & Forecast 2025 to 2035
Penile Cancer Treatment Market Size and Share Forecast Outlook 2025 to 2035
Cervical Cancer Treatment Market Size and Share Forecast Outlook 2025 to 2035
Testicular Cancer Treatment Market
Endometrial Cancer Treatment Market Size and Share Forecast Outlook 2025 to 2035
Biliary Tract Cancers Treatment Market Analysis - Size, Share, and Forecast Outlook 2025 to 2035
Key Players & Market Share in the Biliary Tract Cancers (BTCs) Treatment Industry
Small Cell Lung Cancer (SCLC) Treatment Market Size and Share Forecast Outlook 2025 to 2035
Kinase Inhibitors For Cancer Treatment Market Size and Share Forecast Outlook 2025 to 2035
PD1 Non-Small Cell Lung Cancer Treatment Market - Growth & Outlook 2025 to 2035
Japan Biliary Tract Cancers (BTCs) Treatment Market Growth – Demand, Trends & Forecast 2025-2035
China Biliary Tract Cancers (BTCs) Treatment Market Analysis – Size, Share & Forecast 2025-2035
Germany Biliary Tract Cancers (BTCs) Treatment Market Trends – Demand, Innovations & Forecast 2025-2035
Adoptive Cell Therapy for Cancer Treatment Market
Australia Biliary Tract Cancers (BTCs) Treatment Market Insights – Size, Share & Industry Growth 2025-2035
United States Biliary Tract Cancers (BTCs) Treatment Market Analysis – Size, Share & Trends 2025-2035
Castration-Resistant Prostate Cancer (CRPC) Treatment Market Insights - Demand, Size & Industry Trends 2025 to 2035
Hormone Sensitive Advanced Prostate Cancer Treatment Market Size and Share Forecast Outlook 2025 to 2035
Cancer Registry Software Market Size and Share Forecast Outlook 2025 to 2035
Cancer Biological Therapy Market Size and Share Forecast Outlook 2025 to 2035
Glottic Cancer Treatment Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
